683 Capital Management, LLC - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is ORIAW and the CUSIP is G6780C117. A total of 33 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
683 Capital Management, LLC ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$19,160
-47.3%
239,8000.0%0.00%
-66.7%
Q4 2022$36,378
+17.3%
239,8000.0%0.00%
+50.0%
Q3 2022$31,000
-13.9%
239,8000.0%0.00%
-33.3%
Q2 2022$36,000
-59.6%
239,8000.0%0.00%
-40.0%
Q1 2022$89,000
-61.3%
239,8000.0%0.01%
-37.5%
Q4 2021$230,000
+10.0%
239,8000.0%0.01%0.0%
Q3 2021$209,000239,8000.01%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q1 2022
NameSharesValueWeighting ↓
ANGELO GORDON & CO., L.P. 60,000$584,0000.06%
Empery Asset Management, LP 39,700$6,0000.03%
Radcliffe Capital Management, L.P. 80,001$779,0000.02%
Anson Funds Management LP 15,000$146,0000.01%
Segantii Capital Management Ltd 30,000$292,0000.01%
Arena Capital Advisors, LLC- CA 111,314$17,0000.00%
683 Capital Management, LLC 239,800$36,0000.00%
Atalaya Capital Management LP 100,000$15,0000.00%
MMCAP International Inc. SPC 159,802$24,0000.00%
MARSHALL WACE, LLP 54,995$536,0000.00%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders